UniQure Shares Plummet as FDA Says Inadequate Clinical Data for Huntington’s Therapy



UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company’s gene therapy for Huntington’s disease may be adequate for a…
Reuters Health Information



Source link : https://www.medscape.com/s/viewarticle/clinical-data-novel-huntingtons-gene-therapy-inadequate-fda-2025a1000u4o?src=rss

Author :

Publish date : 2025-11-03 12:18:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version